A Dose Escalation Study to Assess the Safety and Tolerability of HMPL-453 in Patients With Advanced Solid Malignancies

NCT02966171 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
14
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated on 23AUG2018 for safety reasons.

Conditions

Interventions

Sponsor

Hutchison Medipharma Limited